Advertisement

Immunopathogenesis of Stiff-Person Spectrum Disorders

  • Pichet Termsarasab
  • Thananan Thammongkolchai
  • Bashar Katirji
Chapter
  • 111 Downloads

Abstract

Stiff-person spectrum disorders (SPSD) are autoimmune disorders. Glutamic acid decarboxylase (GAD) is an intracellular presynaptic antigen which belongs to a unique category, different from onconeuronal antigens and postsynaptic proteins. However, the pathophysiology and the roles of anti-GAD65 antibodies remain unclear. Controversies regarding anti-GAD65 antibodies include whether the pathophysiology is mainly antibody- or T-cell-mediated and whether the antibodies have direct pathogenic role or just represent a biomarker. Current knowledge gaps also include interaction between anti-GAD65 antibodies and intracellular GAD65 antigen, as well as immunopathogenesis of other less common antibodies associated with SPSD.

Keywords

Stiff-person syndrome Anti-GAD Pathogenesis Immunology Pathophysiology Immunopathogenesis Autoimmunity 

References

  1. 1.
    Lancaster E, Dalmau J. Neuronal autoantigens–pathogenesis, associated disorders and antibody testing. Nat Rev Neurol. 2012;8(7):380–90.  https://doi.org/10.1038/nrneurol.2012.99.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Abbas AK, Lichtman AH, Pillai S. Immunologic tolerance and autoimmunity. In: Abbas AK, Lichtman AH, Pillai S, editors. Cellular and molecular immunology. 9th ed. Philadelphia: Elsevier; 2018. p. 325–50.Google Scholar
  3. 3.
    Pugliese A, Solimena M, Awdeh ZL, Alper CA, Bugawan T, Erlich HA, et al. Association of HLA-DQB1∗0201 with stiff-man syndrome. J Clin Endocrinol Metab. 1993;77(6):1550–3.  https://doi.org/10.1210/jcem.77.6.8263140.CrossRefPubMedGoogle Scholar
  4. 4.
    Dalakas MC, Fujii M, Li M, McElroy B. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology. 2000;55(10):1531–5.  https://doi.org/10.1212/wnl.55.10.1531.CrossRefPubMedGoogle Scholar
  5. 5.
    Hiemstra HS, Schloot NC, van Veelen PA, Willemen SJ, Franken KL, van Rood JJ, et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A. 2001;98(7):3988–91.  https://doi.org/10.1073/pnas.071050898.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Hassin-Baer S, Kirson ED, Shulman L, Buchman AS, Bin H, Hindiyeh M, et al. Stiff-person syndrome following West Nile fever. Arch Neurol. 2004;61(6):938–41.  https://doi.org/10.1001/archneur.61.6.938.CrossRefPubMedGoogle Scholar
  7. 7.
    Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest. 1994;94(5):2125–9.  https://doi.org/10.1172/JCI117567.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Hyoty H. Enterovirus infections and type 1 diabetes. Ann Med. 2002;34(3):138–47.CrossRefGoogle Scholar
  9. 9.
    Tong JC, Myers MA, Mackay IR, Zimmet PZ, Rowley MJ. The PEVKEK region of the pyridoxal phosphate binding domain of GAD65 expresses a dominant B cell epitope for type 1 diabetes sera. Ann N Y Acad Sci. 2002;958:182–9.  https://doi.org/10.1111/j.1749-6632.2002.tb02966.x.CrossRefPubMedGoogle Scholar
  10. 10.
    Filippi CM, von Herrath MG. Viral trigger for type 1 diabetes: pros and cons. Diabetes. 2008;57(11):2863–71.  https://doi.org/10.2337/db07-1023.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Lohmann T, Hawa M, Leslie RD, Lane R, Picard J, Londei M. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. Lancet. 2000;356(9223):31–5.  https://doi.org/10.1016/S0140-6736(00)02431-4.CrossRefPubMedGoogle Scholar
  12. 12.
    Lohmann T, Londei M, Hawa M, Leslie RD. Humoral and cellular autoimmune responses in stiff person syndrome. Ann N Y Acad Sci. 2003;998:215–22.  https://doi.org/10.1196/annals.1254.024.CrossRefPubMedGoogle Scholar
  13. 13.
    Baizabal-Carvallo JF, Jankovic J. Stiff-person syndrome: insights into a complex autoimmune disorder. J Neurol Neurosurg Psychiatry. 2015;86(8):840–8.  https://doi.org/10.1136/jnnp-2014-309201.CrossRefPubMedGoogle Scholar
  14. 14.
    Burton AR, Baquet Z, Eisenbarth GS, Tisch R, Smeyne R, Workman CJ, et al. Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells. J Immunol. 2010;184(9):4863–70.  https://doi.org/10.4049/jimmunol.0903728.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Skorstad G, Hestvik AL, Vartdal F, Holmoy T. Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome. J Autoimmun. 2009;32(1):24–32.  https://doi.org/10.1016/j.jaut.2008.10.002.CrossRefPubMedGoogle Scholar
  16. 16.
    Skorstad G, Hestvik AL, Torjesen P, Alvik K, Vartdal F, Vandvik B, et al. GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence. Eur J Neurol. 2008;15(9):973–80.  https://doi.org/10.1111/j.1468-1331.2008.02221.x.CrossRefPubMedGoogle Scholar
  17. 17.
    Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW. Chronic thyroiditis and autoimmunization. J Am Med Assoc. 1957;164(13):1439–47.  https://doi.org/10.1001/jama.1957.02980130015004.CrossRefPubMedGoogle Scholar
  18. 18.
    Walikonis JE, Lennon VA. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Mayo Clin Proc. 1998;73(12):1161–6.  https://doi.org/10.4065/73.12.1161.CrossRefPubMedGoogle Scholar
  19. 19.
    Manto MU, Laute MA, Aguera M, Rogemond V, Pandolfo M, Honnorat J. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol. 2007;61(6):544–51.  https://doi.org/10.1002/ana.21123.CrossRefPubMedGoogle Scholar
  20. 20.
    Nemni R, Caniatti LM, Gironi M, Bazzigaluppi E, De Grandis D. Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodies. Neurology. 2004;62(11):2101–2.  https://doi.org/10.1212/01.wnl.0000127446.61806.2f.CrossRefPubMedGoogle Scholar
  21. 21.
    Chang T, Alexopoulos H, Pettingill P, McMenamin M, Deacon R, Erdelyi F, et al. Immunization against GAD induces antibody binding to GAD-independent antigens and brainstem GABAergic neuronal loss. PLoS One. 2013;8(9):e72921.  https://doi.org/10.1371/journal.pone.0072921.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Rakocevic G, Alexopoulos H, Dalakas MC. Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder. BMC Neurol. 2019;19(1):1.  https://doi.org/10.1186/s12883-018-1232-z.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Irani SR. ‘Moonlighting’ surface antigens: a paradigm for autoantibody pathogenicity in neurology? Brain. 2016;139(Pt 2):304–6.  https://doi.org/10.1093/brain/awv364.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Pichet Termsarasab
    • 1
  • Thananan Thammongkolchai
    • 1
  • Bashar Katirji
    • 2
  1. 1.Division of NeurologyFaculty of Medicine Ramathibodi Hospital, Mahidol UniversityBangkokThailand
  2. 2.Department of NeurologyUniversity Hospitals Cleveland Medical Center, Case Western Reserve UniversityClevelandUSA

Personalised recommendations